The CFP/PPy//RGO/ c MWCNT asymmetric all-solid-state supercapacitor with high energy density and excellent cycle life was developed.

The flexible supercapacitors (SCs) of the conventional sandwich-type structure have poor flexibility due to the large thickness of the final entire device. Herein, we have fabricated a highly flexible asymmetric SC using manganese dioxide (MnO₂) and reduced graphene oxide (RGO) nanosheet-piled hydrogel films and a novel bacterial cellulose (BC)-filled polyacrylic acid sodium salt-Na₂SO₄ (BC/PAAS-Na₂SO₄) neutral gel electrolyte. Apart from being environmentally friendly, this BC/PAAS-Na₂SO₄ gel electrolyte has high viscosity and a sticky property, which enables it to combine two electrodes together. Meanwhile, the intertangling of the filled BC in the gel electrolyte hinders the decrease of the viscosity with temperature, and forms a separator to prevent the two electrodes from short-circuiting. Using these materials, the total thickness of the fabricated device does not exceed 120 μm. This SC device demonstrates high flexibility, where bending and even rolling have no obvious effect on the electrochemical performance. In addition, owing to the asymmetric configuration, the cell voltage of this flexible SC has been extended to 1.8 V, and the energy density can reach up to 11.7 Wh kg⁻¹ at the power density of 441 W kg⁻¹. This SC also exhibits a good cycling stability, with a capacitance retention of 85.5% over 5000 cycles.

Innovation in the design of Li-ion rechargeable batteries is necessary to overcome safety concerns and meet energy demands. In this regard, a new generation of Li-ion batteries (LIBs) in the form of all-solid-state batteries (ASSBs) has been developed, attracting a great deal of attention for their high-energy density and excellent mechanical-electrochemical stability. This review describes the current state of research and development on ASSB technology. To this end, study of the literature and patents as well as market analysis over the last two decades were carried out, highlighting how scientific achievements have informed the application of commercially profitable ASSBs. Analyzing the patents registered over the past 20 years revealed that the number of them had increased exponentially-from only few per year in early 2000 to more than 342 in 2020. Published literature and patents on the topic declare a solid-state electrolyte (SSE) to be the main component of ASSBs, and most patented examples are referred to as solid inorganic electrolytes (SIEs), followed by solid polymer electrolytes (SPEs) and solid hybrid electrolytes (SHEs) in popularity. Investigation of company websites, social media profiles, reports, and academic publications identified 93 companies associated with ASSBs. A list of leading businesses in the solid-state battery sector was compiled, out of which 36 provided information on the ASSB units in their product portfolio for detailed analysis.

The alkaline milieu of chronic wounds severely impairs the therapeutic effect of antibiotics, such as rifampicin; as such, the development of new drugs, or the smart delivery of existing drugs, is required. Herein, two innovative polyelectrolyte nanoparticles (PENs), composed of an amphiphilic chitosan core and a polycationic shell, were synthesized at alkaline pH, and in vitro performances were assessed by ¹H NMR, elemental analysis, FT-IR, XRD, DSC, DLS, SEM, TEM, UV/Vis spectrophotometry, and HPLC. According to the results, the nanostructures exhibited different morphologies but similar physicochemical properties and release profiles. It was also hypothesized that the simultaneous use of the nanosystem and an antioxidant could be therapeutically beneficial. Therefore, the simultaneous effects of ascorbic acid and PENs were evaluated on the release profile and degradation of rifampicin, in which the results confirmed their synergistic protective effect at pH 8.5, as opposed to pH 7.4. Overall, this study highlighted the benefits of nanoparticulate development in the presence of antioxidants, at alkaline pH, as an efficient approach for decreasing rifampicin degradation.